Skip to main content

Cindy Louise Amundsen, MD

Headshot of Cindy Amundsen
Roy T. Parker, M.D. Distinguished Professor of Obstetrics and Gynecology, in the School of Medicine
Campus Mail: 5324 McFarland Drive Suite 310, Box 3192, Durham, NC 27617
Phone: (919) 401-1006

- Application of nerve stimulation (Interstim therapy) for control of continence
- Evaluation of botox therapy for urinary urge incontinence
- Evaluation and treatment for nocturnal voiding
- Application of nerve stimulation for control of continence and enable proper voiding in individuals with Spinal cord injuries
- Application of nerve stimulation for urinary retention
- Minimally invasive prolapse surgery using graft material for enhancing pelvic organ prolapse repairs
-Treatment for stress urinary incontinence with minimally invasive techniques
- Evaluation of the urinary microbiome as it relates to recurrent urinary tract infections and lower urinary tract symptoms

Education and Training

  • Urogynecology Fellowship, Surgery, University of Texas Health Science Center San Antonio, 1995 - 1996
  • Residency, Obstetrics & Gynecology, University of Texas Health Science Center San Antonio, 1991 - 1995
  • M.D., University of Tennessee Health Science Center, 1991


  • American Board of Obstetrics and Gynecology, 1997
  • Female Pelvic Medicine and Reconstructive Surgery, 2013


Lower Urinary Tract Dysfunction / Pelvic Floor Disorders

View Publications

Selected Grants and Awards


Kisby, Cassandra K., Anthony Visco, and Cindy Amundsen. “Response to "Intraurethral Lidocaine Use During Urodynamic Testing Deserves Further Study".” Female Pelvic Med Reconstr Surg 26, no. 7 (July 2020): 465.

Full Text

Harvie, Heidi S., Cindy L. Amundsen, Simon J. Neuwahl, Amanda A. Honeycutt, Emily S. Lukacz, Vivian W. Sung, Rebecca G. Rogers, et al. “Cost-Effectiveness of Sacral Neuromodulation versus OnabotulinumtoxinA for Refractory Urgency Urinary Incontinence: Results of the ROSETTA Randomized Trial.” J Urol 203, no. 5 (May 2020): 969–77.

Full Text

Gill, Bradley, Cindy L. Amundsen, Sonia Thomas, Lindsey Barden, Ariana Smith, Yuko Komesu, and J Eric Jelovsek. “INTRAOPERATIVE PREDICTORS OF SACRAL NEUROMODULATION IMPLANTATION & TREATMENT RESPONSE - RESULTS FROM THE ROSETTA TRIAL.” In Journal of Urology, 203:E1020–21. LIPPINCOTT WILLIAMS & WILKINS, 2020.


Clemens, J Quentin, Jonathan B. Wiseman, Abigail R. Smith, Cindy L. Amundsen, Claire C. Yang, Megan S. Bradley, Ziya Kirkali, Nnenaya Q. Agochukwu, Anne P. Cameron, and Anne P. LURN Study Group. “Prevalence, subtypes, and correlates of nocturia in the symptoms of Lower Urinary Tract Dysfunction Research Network cohort.” Neurourol Urodyn 39, no. 4 (April 2020): 1098–1107.

Full Text

Amundsen, Cindy L., Margaret E. Helmuth, Abigail R. Smith, John O. L. DeLancey, Catherine S. Bradley, Kathryn E. Flynn, Kimberly S. Kenton, et al. “Longitudinal changes in symptom-based female and male LUTS clusters.” Neurourol Urodyn 39, no. 1 (January 2020): 393–402.

Full Text

VanDusen, Keith W., Sarada Eleswarpu, Eugene W. Moretti, Michael J. Devinney, Donna M. Crabtree, Daniel T. Laskowitz, Marty G. Woldorff, et al. “The MARBLE Study Protocol: Modulating ApoE Signaling to Reduce Brain Inflammation, DeLirium, and PostopErative Cognitive Dysfunction.” J Alzheimers Dis 75, no. 4 (2020): 1319–28.

Full Text

Cameron, Anne P., Jonathan B. Wiseman, Abigail R. Smith, Robert M. Merion, Brenda W. Gillespie, Catherine S. Bradley, Cindy L. Amundsen, et al. “Are three-day voiding diaries feasible and reliable? Results from the Symptoms of Lower Urinary Tract Dysfunction Research Network (LURN) cohort.” Neurourol Urodyn 38, no. 8 (November 2019): 2185–93.

Full Text

McKee, Dana C., Eric J. Gonzalez, Cindy L. Amundsen, and Warren M. Grill. “Randomized Controlled Trial to Assess the Impact of High Concentration Intraurethral Lidocaine on Urodynamic Voiding Parameters.” Urology 133 (November 2019): 72–77.

Full Text

Andy, Uduak U., Cindy L. Amundsen, Emily Honeycutt, Alayne D. Markland, Gena Dunivan, Keisha Y. Dyer, Nicole B. Korbly, et al. “Sacral neuromodulation versus onabotulinumtoxinA for refractory urgency urinary incontinence: impact on fecal incontinence symptoms and sexual function.” Am J Obstet Gynecol 221, no. 5 (November 2019): 513.e1-513.e15.

Full Text